The latest inspection report of the General Pharmaceutical Council (GPhC) revealed that nine pharmacies did not meet their standards out of 52 pharmacies that
were inspected between January 2023 and May 2023.
Pharmacies are inspected on five principles - Governance, Staff, Premises, Services including medicines management and Equipment and facilities. Out of nine, eight
pharmacies did not meet GPhC standard of governance which is defined to safeguard the health, safety and wellbeing of patients and the public.
Six pharmacies did not meet the GPhC standard of principle four which defines the way in which pharmacy services, including the management of medicines and medical
devices, are delivered safeguards the health, safety and wellbeing of patients and the public.
The purpose of these standards is to create and maintain the right environment, both organisational and physical, for the safe and effective practice of pharmacy.
The standards apply to all pharmacies registered with GPhC.
E-pharmacy, a digital platform also known as internet pharmacy or online pharmacy, has emerged as an escape route to longstanding queues at pharmacy stores
across almost all regions of the world, especially during the Covid-19 health crisis realm.
They have long been recognised to act promptly in public health response, like ensuring an effective medicine supply system, resolving and monitoring drug shortage
issues, educating about the proper use of PPE, promoting remote pharmacy services, and conducting drug evaluation and active surveillance.
These factors will support in easing the load on healthcare facilities during the ongoing pandemic, eventually adding value to patients and the healthcare system.
Overall, the e-pharmacy market size is expanding in terms of valuation on the back of regulations and standards laid by the respective governments.
As per a recent study by Global Market Insights, the global e-pharmacy industry accounted for a business share of $68 billion in 2021 with an anticipated growth
rate of 16.8 per cent through 2028.
Pharmacy Supervision Practice Group, an organisations from across the community pharmacy sector, who have come together to look into the future "supervision" in
community pharmacy, have published their final report.
Over the course of nine collaborative and positive workshop-style discussions the Supervision Practice Group aimed to provide recommendations to reframe legislation,
regulation and professional standards and guidance to achieve a new vision for community pharmacy.
The group have produced a report which makes several recommendations on the subjects of:
* the legislation relating to "supervision";
* the temporary absence of the RP from the pharmacy;
* delegation;
* the preparation and assembly of medicines when the RP is not signed in.
The group have provided recommendations on which the Department of and Social Care and the regulators can draft specifically worded revisions to legislation and
regulatory standards. These specific legislative and regulatory changes that are proposed by government and regulators will be subject to a full consultation process.
Blackwells Chemist, a community pharmacy in South East London did not meet all the General Pharmaceutical Council (GPhC) standards.
The pharmacy was inspected on Thursday (01 June) and it was found it did not keep all its records up to date and accurate, particularly its responsible pharmacist
records. Investigation report stated that the principle of Governance and principle of Services, including medicines management was 'not met at all'.
Under the principle Governance, the report stated: "The pharmacy generally manages the risks associated with its services adequately. People using the pharmacy can
provide feedback or raise concerns. And staff generally protect people's personal information well. Team members know what to do to help protect the welfare of a
vulnerable person. The pharmacy has written procedures, but these are not easily accessible to team members to refer to. And they are not regularly updated. So,
they may be less useful to staff, and may not reflect current best practice."
In the inspection it was found that the pharmacy does not always store its medicines properly. It cannot show that it stores all its medicines requiring cold
storage at the appropriate temperatures.
The professional leadership body for pharmacists has urged the General Pharmaceutical Council's (GPhC) to make it mandatory to have a chief pharmacist within
organisations to ensure transparency for patients, the public and pharmacy staff.
On 23 January, the GPhC launched a consultation seeking views on the new draft Standards for Chief Pharmacists it has developed to strengthen pharmacy governance.
These standards outlined the professional responsibilities and qualifications required by a chief pharmacist to support their organisation and its staff to deliver
"safe and effective" pharmacy services.
The pharmacy regulator highlighted the importance of having a registered chief pharmacist meeting these standards in hospitals (or relevant settings) to benefit
from the new legislation regarding accidental errors.
In response to the consultation, the RPS expressed that while meeting these standards could enhance pharmacy governance, they may not provide the framework needed
to fully support staff in reporting and learning from errors.
Community Pharmacy England has published new guidance to help members to complete the 2022/23 Data Security and Protection Toolkit (DSPTK).
The Toolkit is used to make a pharmacy's information governance (IG) declaration and the deadline is Friday (30 June).
Community Pharmacy England collaborated with the NHS DSPTK team to keep the workload associated with Toolkit completion manageable whilst maintaining the
appropriate data security protections.
Key differences in this year's Toolkit include- improvements to the Toolkit's layout; improvements to the question wording and pharmacy-specific tips; and the
Toolkit displays the answers submitted by the pharmacy in the previous submission for various questions, allowing pharmacy owners to simply confirm that the
information remains accurate and adjust this if necessary.
The NHS Parent Organisation Code (POC) headquarters (HQ) batch submission feature also continues to enable to allow pharmacy owners (that own three or more
pharmacies) to complete a single submission for all their premises.
The Department of Health and Social Care (DHSC) has published plans to amend current pharmacy legislation on dispensing errors and clarify how registered
pharmacies are governed.
The Department's response to a public consultation on rebalancing medicines legislation and pharmacy regulation programme first proposed in summer 2018 was
delayed due to Brexit and the Covid-19 pandemic.
The programme aims to clarify and strengthen the organisational governance arrangements of registered pharmacies, specifically to define and clarify the core
purpose of the Responsible Pharmacist and Superintendent Pharmacist roles.
It will also give the General Pharmaceutical Council (GPhC) powers to define in professional standards how those roles are fulfilled.
Duncan Rudkin, the CEO of the General Pharmaceutical Council (GPhc) has highlighted the importance of strengthening pharmacy governance to provide clarity
around how pharmacies are organised and managed.
This will ensure that patients and the public continue to receive safe and effective pharmacy care, he said while speaking at the annual Sigma Conference in
London on Sunday (5 November).
According to him, there could be rules that outlined the essential roles and responsibilities of responsible pharmacists, and professional standards for
responsible pharmacists, superintended pharmacists and chief pharmacists.
He also announced that the GPhC will be shortly launching a consultation to integrate a new set of standards for the statutory role of hospital chief
pharmacists "which up until recently has never been recognised in law." It is expected to be launched by early January 2024.
However, Duncan, emphasised that they cannot start the work on standards for responsible and superintendent pharmacists until they know the government plans
in relation to supervision.
"Because of course, the responsible pharmacists' regime, and the supervision regime are in many ways intertwined, and can't certainly be looked at separately.
In a bid to bolster professional leadership within the pharmacy sector, the four government Chief Pharmaceutical Officers (CPhOs) have embarked on a
significant initiative, forming the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB).
In a recent communication, all pharmacists and pharmacy technicians received confirmation of the board members selected by the CPhOs, alongside a note from the
board's appointed chair, who was chosen collectively by the four CPhOs and reports directly to the CPhO for England.
Over three years, the 21-member Board will implement recommendations from the UK Commission on Pharmacy Professional Leadership's report aimed to enhance
professional fulfillment among pharmacists while simultaneously augmenting patient safety standards.
This announcement also follows with the appointment of Sir Hugh Taylor as its Independent Chair and the appointment of Independent Expert Members who expressed
his delight over the role's "potential to lead and support collaboration across the professions in the UK".
However, the move has been met with cautious optimism from the Pharmacists' Defence Association (PDA), urging the new board to uphold transparency and openness
to garner trust among pharmacists.
The General Pharmaceutical Council (GPhC) has developed new draft Standards for Chief Pharmacists to strengthen pharmacy governance.
It has set out the professional responsibilities as well as described the knowledge, conduct, and performance required by a chief pharmacist (or equivalent) to
support their organisation and its staff to deliver "safe and effective" pharmacy services.
The pharmacy regulator has also launched a consultation to find out what patients, carers, and members of the public think about the new draft standards.
Participants can share their views "if there are any settings in which the standards could not be applied or met and any positive or negative impacts of the
proposals," it said.
The survey will open for 12 weeks, from 23 January to 16 April 2024.
The Pharmacists' Defence Association (PDA) has begun conciliation with 86 pharmacy companies to safeguard the interests of former LloydsPharmacy pharmacists.
The Advisory, Conciliation and Arbitration Service (Acas), a government agency, serves as a mediator between companies and employees to resolve disputes. If the
ongoing mediation prove unsuccessful, individual employees retain the option to file claims in the employment tribunal, the PDA has said.
The ongoing dispute centres around employers potentially failing to conduct the required consultation under the Transfer of Undertakings (Protection of Employment)
regulations (TUPE) with employees and their representatives during employee transfers, the PDA said.
The TUPE legislation, known for its complexity and technical nature, applies when a section of the company, like a pharmacy sold as an asset using standard disposal,
undergoes a transfer.
According to NHS England's recent pharmaceutical list, LloydsPharmacy has either sold or shuttered 461 branches since September 2022. According to NHSE data, as of
June 30, the pharmacy chain operates approximately 512 pharmacies in England. This positions it as the third-largest chain after Boots UK and Well Pharmacy.
New legislative orders approved by the Privy Council will give the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI)
powers to set professional standards for Responsible Pharmacists, Superintendent Pharmacists and Chief Pharmacists.
The Pharmacy (Preparation and Dispensing Errors - Hospital (and Other Pharmacy Services) Order 2022 and the Pharmacy (Responsible Pharmacists, Superintendent
Pharmacists etc.) Order 2022 have been published and are expected to come into force in December 2022.
Trevor Patterson, Chief Executive of the Pharmaceutical Society NI said: "We have been working with our colleagues in the GPhC and Government for some time on these
two pieces of important legislation and we are delighted they have now reached the statute books.
"Both Orders enable and enhance the powers we, and the GPhC, have to define the roles and responsibilities of Responsible, Superintendent and Chief Pharmacists,
respectively. They also create protections against criminal prosecution for hospital pharmacists where an inadvertent error is made either in dispensing or assembly,
in certain defined circumstances, similar to the protections available to colleagues working in community/registered pharmacy settings. Provisions that allow the
appointment of a Deputy Registrar for our organisation will also be introduced.
Online pharmacy PillTime has taken a step to boost its prescription growth by implementing new Patient Medication Record (PMR) system Titan in its
state-of-the-art premises.
PillTime moved to new, expanded 26,000sqft premises in Cribbs Causeway on the edge of Bristol earlier this year, where it has also installed state-of-the-art
robotics in a bid to significantly enhance future productivity and capacity.
Teething problems over Easter weekend saw PillTime struggling to seamlessly integrate all the new systems and processes while physically moving premises which
affected service delivery and customer support.
However, CEO Leighton Humphreys was supported by Tariq Muhammad, CEO of Invatech Health, who is a former community pharmacist and has worked with independent
pharmacies around the UK as well as larger online businesses, to integrate Titan into their workflows.
Alongside integration work, Muhammad and his team supported PillTime with necessary design, governance and pharmacy expertise as the company struggled to meet its
usual high standards for dispensing medicines to patients.
The General Pharmaceutical Council's Investigating Committee took decisive action on March 25, 2024, by issuing a warning to Dilsha Kiran Shah,
registration number: 2049787, for her conduct as Superintendent Pharmacist of Jhoots Healthcare Ltd.
Miss Shah's failure to uphold the Medicines Act 1968, specifically in ensuring the proper management of medicinal products, triggered this warning.
The Act mandates supervision in "keeping, preparing, and dispensing medicinal products other than those on a general sale list."
Moreover, pharmacies are inspected on five principles - Governance, Staff, Premises, Services including medicines management, and Equipment and facilities to
meet the right standards.
The alarm was initially raised in August 2021 when a Jhoots Healthcare Ltd pharmacy branch under Miss Shah's supervision operated without a responsible pharmacist.
Despite explicit instructions, pharmacy staff were allegedly instructed to proceed without proper supervision, raising grave concerns regarding patient safety.
The Pharmacists' Defence Association (PDA) has submitted a 17-page contribution to the commission on the future of pharmacy professional leadership and
encourages pharmacists to engage in the overall discussion.
The association wants to ensure that the voice of its members is heard in the discussions about the future of professional leadership, which has been initiated by
the four government Chief Pharmaceutical Officers.
The PDA has published its first formal contribution to the commission, in its response it raised concern on the current exercise is being rushed and a call for the
review to be conducted in a more sensible timeframe, one which enables the engagement of the whole profession.
It has urged on being supportive of the creation of a Royal College of Pharmacists to take custodianship of the training and education for pharmacists and to set the
requisite standards, whilst still relying upon the profession's regulators to undertake the accreditation role.
Pharmacists, along with workers from other public sector workplaces, marched on 8 September demanding that the Scottish government take all available action
to mitigate the biggest reduction in living standards workers will have experienced for generations.
Pharmacists Defence' Association (PDA) members participated in the Scottish Trade Unions Congress (STUC) march to let the government know that "Scotland demands
better".
Paul Flynn, PDA national officer, said: "Pharmacists will be unwelcomely familiar with diminished purchasing power and a squeeze on household budgets for patients,
colleagues and pharmacists but what we will see this year and into 2023 will make previous experience pale by comparison."
The march organised by STUC saw thousands of workers, activists and concerned individuals march through the centre of Edinburgh's Historic Old Town in good spirits
while bearing flags and banners, chanting, singing, and calling for change in Scotland.
Health secretary Sajid Javid and chancellor of the exchequer Rishi Sunak have both resigned on Tuesday (July 5) after a slew of scandals undermined the
government of prime minister Boris Johnson.
Javid and Sunak sent resignation letters to Johnson within minutes of each other in which both took aim at his ability to run an administration that adhered to
standards.
The resignations came as Johnson was apologising for appointing a lawmaker to a role involved in offering pastoral care, even after being briefed that the politician
had been the subject of complaints about sexual misconduct.
In his resignation letter to Johnson, Javid said "it is clear to me that this situation will not change under your leadership - and you have therefore lost my
confidence too".
He was appointed to lead the Department of Health and Social Care in June 2021, when his predecessor Matt Hancock quit after being caught having an affair with an
adviser, in breach of social distancing guidelines.
The Pharmacists' Defence Association (PDA) has welcomed the Westminster government's move to backtracked from their plan to remove a large number of rights and
standards and is having to overhaul the Retained EU Law Bill.
This had included a number of employment rights, including TUPE transfers and the Working Time Directive, which had been established in the UK from EU law.
The Bill's 'sunset clause' was originally going to automatically repeal any EU law not enshrined in UK law by the end of 2023. Critics of the Bill were concerned
that this gave the government powers to reform or remove laws without normal Parliamentary scrutiny.
"This would have abolished many improvements to workers' rights which were enacted through the EU legislature," said PDA.
The Royal Pharmaceutical Society (RPS) has called on employers, governments and NHS organisations to provide pharmacists with regular protected learning
time (PLT) within working hours to develop their skills in clinical delivery, education, research and leadership.
RPS workforce wellbeing survey showed an average 42 per cent of pharmacists were not given any PLT, a figure which rose to 55 per cent in community pharmacy. Most
were unable to engage in professional development activities as part of their working day because of their responsibility to deliver frontline clinical services to
patients.
This means learning is often undertaken outside of working hours, increasing pressure on individuals and impacting their work/life balance.
The survey showed that 48 per cent of respondents identified a lack of PLT as negatively affecting their mental health and wellbeing and that 88 per cent were at
high risk of burnout.
PLT improves the quality of patient care through professional practice and reflection, helping to develop insights, maintain and refine care standards and increase
confidence. It facilitates continuous professional development (CPD), ensuring that skills and knowledge are up to date.
The Indian government has suspended manufacturing in over 40 pharmaceutical companies based on a risk-based assessment conducted earlier in the year across 162
firms, according to the data provided by Union Health Minister Mansukh Mandaviya in Parliament on Thursday (Aug. 10).
"Overall, a sum of 143 show-cause notices has been issued," Mandaviya said.
There have been numerous recent incidents involving accusations from foreign countries regarding the contamination of syrups, eye drops, and ointments manufactured
in India. Countries such as the Gambia, Uzbekistan, and Cameroon have linked the deaths of 70, 18, and six children, respectively, to cough syrups contaminated in
India.
Licenses for specific products have been either temporarily suspended or fully revoked for an additional 66 companies. In one case, an FIR has been registered,
and in 21 cases, warning letters have been issued following inspections by both the Central Drugs Standard Control Organization and State authorities, the Minister
added.
Meanwhile, the Indian government has mandated rigorous testing for cough syrups before export. Starting June 1, any cough syrup must possess a government
laboratory-issued certificate of analysis before being exported, the government said in a notice dated May 22.